13 aprile 2021 | 10.01 LETTURA: 6 minuti
Company to launch Hemanext ONE® RBC Processing and Storage System in select European markets in 2021, with wider distribution in Europe and the Americas in 2022 and future years
Product now available in Norway, Blood centers in Italy, Switzerland, and France expected to complete validations later this year
LEXINGTON, Mass., April 13, 2021 /PRNewswire/ Hemanext Inc., a privately held medical technology company, today announced it has received a CE Certificate of Conformity for the CE Mark for its Hemanext ONE Red Blood Cell (RBC) Processing and Storage System, allowing the innovative medical device to be sold in European markets. Blood center validations required for the adoption of the Hemanext ONE RBC Processing and Storage System were completed in Norway in 2020. The company expects blood centers in Italy, Switzerland, and France to complete validations in 2021. Hemanext plans to secure additional validations
The medical issues that led to Tuesday’s recommended pause in administration of the Johnson & Johnson vaccine are exceedingly rare, government health officials said at a news conference.
Six women who received the vaccine are known to have suffered cerebral venous sinus thrombosis – a rare form of stroke – also had low platelet counts in their blood. Platelets help your blood clot to stop bleeding.
But the illness is severe. One of the six women has died, authorities said, and another is in critical condition. All the known cases are among women between the ages of 18 and 48.
So what should you look for if you are one of the 6.8 million people who have received Johnson & Johnson’s one-dose vaccine, or are scheduled to receive it soon?
COVID Spawns Completely New Category Of Organ Transplants usf.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from usf.edu Daily Mail and Mail on Sunday newspapers.
email article
Evidence remained insufficient to support broad screening for vitamin D deficiency in adults, the U.S. Preventive Services Task Force (USPSTF) said.
As it did in 2014, USPSTF determined that the lack of direct evidence precluded the assessment of the balance of benefits and harms of routine screening in asymptomatic, community-dwelling adults.
Detecting vitamin D deficiency itself poses several challenges in particular. It is possible that 25(OH)D the major circulating form of vitamin D may not be the best measure of deficiency, and vitamin D requirements may vary by sex and race, according to Alex Krist, MD, MPH, of Virginia Commonwealth University in Richmond, and colleagues in
Six women who had the vaccine suffered from cerebral venous sinus thrombosis, a rare form of stroke. Here’s what to know about symptoms of blood clots if you received the vaccine.